Rubius Therapeutics (STU:5RT) Scaled Net Operating Assets : -0.01 (As of Dec. 2022)

View and export this data going back to 2019. Start your Free Trial

What is Rubius Therapeutics Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Rubius Therapeutics's operating assets for the quarter that ended in Dec. 2022 was €3.90 Mil. Rubius Therapeutics's operating liabilities for the quarter that ended in Dec. 2022 was €6.46 Mil. Rubius Therapeutics's Total Assets for the quarter that ended in Sep. 2022 was €172.40 Mil. Therefore, Rubius Therapeutics's scaled net operating assets (SNOA) for the quarter that ended in Dec. 2022 was -0.01.

Rubius Therapeutics Scaled Net Operating Assets Historical Data

The historical data trend for Rubius Therapeutics's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rubius Therapeutics Scaled Net Operating Assets Chart

Rubius Therapeutics Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Scaled Net Operating Assets

Get a 7-Day Free Trial

0.57

0.19

0.26

-0.01

Rubius Therapeutics Quarterly Data
	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22
Scaled Net Operating Assets	Get a 7-Day Free Trial															0.19	0.23	0.26	0.20	-0.02

Competitive Comparison of Rubius Therapeutics's Scaled Net Operating Assets

For the Biotechnology subindustry, Rubius Therapeutics's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Rubius Therapeutics's Scaled Net Operating Assets Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Rubius Therapeutics's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Rubius Therapeutics's Scaled Net Operating Assets falls into.

Rubius Therapeutics Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Rubius Therapeutics's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2022 is calculated as

	Scaled Net Operating Assets (SNOA)		(A: Dec. 2022 )
=	(Operating Assets (A: Dec. 2022 )	-	Operating Liabilities (A: Dec. 2022 ))	/	Total Assets (A: Dec. 2021 )
=	(3.903	-	6.456)	/	281.449
=	-0.01

where

	Operating Assets		(A: Dec. 2022 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	21.778	-	17.875
=	3.903

	Operating Liabilities		(A: Dec. 2022 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	7.494	-	0	-	1.038
=	6.456

Rubius Therapeutics's Scaled Net Operating Assets (SNOA) for the quarter that ended in Dec. 2022 is calculated as

	Scaled Net Operating Assets (SNOA)		(Q: Dec. 2022 )
=	(Operating Assets (Q: Dec. 2022 )	-	Operating Liabilities (Q: Dec. 2022 ))	/	Total Assets (Q: Sep. 2022 )
=	(3.903	-	6.456)	/	172.404
=	-0.01

where

	Operating Assets		(Q: Dec. 2022 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	21.778	-	17.875
=	3.903

	Operating Liabilities		(Q: Dec. 2022 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	7.494	-	0	-	1.038
=	6.456

Rubius Therapeutics Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Rubius Therapeutics's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Rubius Therapeutics (STU:5RT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Rubius Therapeutics Inc (STU:5RT) » Definitions » Scaled Net Operating Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

124 Washington Street, Suite 101, Foxborough, MA, USA, 02035

Website

https://www.rubiustx.com

Rubius Therapeutics Inc develops red cell therapeutics (RCTs) for the treatment of patients with rare diseases, cancer, and autoimmune diseases.

Rubius Therapeutics (STU:5RT) Headlines

No Headlines